Latest filing published 08 Nov 2024 for Vor Biopharma Inc., €162.
Insider track record
Amy Quinlan: trading record in brief
This profile gathers the share dealings of Amy Quinlan in Vor Biopharma Inc. Over a trading history stretching from 1 August 2024 to 6 November 2024, the count stands at 5 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 8 November 2024, reports a share grant of €162 in Vor Biopharma Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Amy Quinlan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 206 shares@ US$0.8622.7% of flowCommon StockSEC:0001415889-24-026432:0
- 343 shares@ US$0.8035.4% of flowCommon StockSEC:0001415889-24-026134:0
- 206 shares@ US$0.873.9% of flowCommon StockSEC:0001415889-24-022767:1
- 4,402 shares@ US$0.8379.0% of flowCommon StockSEC:0001415889-24-022767:2
- 343 shares@ US$0.9441.9% of flowCommon StockSEC:0001415889-24-022767:0
5 of 5 declarations
